PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Vir Biotechnology, Inc. (VIR)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US92764N1028

CUSIP

92764N102

Sector

Healthcare

IPO Date

Oct 11, 2019

Highlights

Market Cap

$928.23M

EPS (TTM)

-$3.93

Total Revenue (TTM)

$78.62M

Gross Profit (TTM)

$64.40M

EBITDA (TTM)

-$548.84M

Year Range

$6.62 - $13.09

Target Price

$29.50

Short %

6.74%

Short Ratio

7.28

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
VIR vs. DNA VIR vs. CRT VIR vs. RXRX
Popular comparisons:
VIR vs. DNA VIR vs. CRT VIR vs. RXRX

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Vir Biotechnology, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-40.00%-30.00%-20.00%-10.00%0.00%10.00%20.00%JuneJulyAugustSeptemberOctoberNovember
-34.74%
12.93%
VIR (Vir Biotechnology, Inc.)
Benchmark (^GSPC)

Returns By Period

Vir Biotechnology, Inc. had a return of -30.91% year-to-date (YTD) and -29.37% in the last 12 months.


VIR

YTD

-30.91%

1M

-8.67%

6M

-34.74%

1Y

-29.37%

5Y (annualized)

-11.51%

10Y (annualized)

N/A

^GSPC (Benchmark)

YTD

24.72%

1M

1.67%

6M

12.93%

1Y

30.55%

5Y (annualized)

13.88%

10Y (annualized)

11.16%

Monthly Returns

The table below presents the monthly returns of VIR, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-6.56%19.57%-9.88%-16.49%21.39%-13.34%14.16%-18.70%-9.32%0.00%-30.91%
202316.75%-22.84%2.06%8.08%6.04%-8.02%-42.60%-10.09%-25.99%-15.37%19.67%6.01%-60.25%
2022-18.01%-26.62%2.10%-20.88%26.83%-1.32%9.19%-14.60%-18.82%14.00%28.39%-10.31%-39.55%
2021141.00%-2.96%-18.14%-6.89%-12.21%12.81%-24.60%44.57%-15.56%-13.30%25.68%-11.70%56.35%
2020111.77%74.62%-26.30%-10.97%12.03%19.87%16.57%-15.24%-15.19%-8.42%1.40%-16.00%112.96%
20190.57%-15.25%5.23%-10.31%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of VIR is 23, indicating that it is in the bottom 23% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of VIR is 2323
Combined Rank
The Sharpe Ratio Rank of VIR is 2222
Sharpe Ratio Rank
The Sortino Ratio Rank of VIR is 2222
Sortino Ratio Rank
The Omega Ratio Rank of VIR is 2323
Omega Ratio Rank
The Calmar Ratio Rank of VIR is 2727
Calmar Ratio Rank
The Martin Ratio Rank of VIR is 2020
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Vir Biotechnology, Inc. (VIR) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for VIR, currently valued at -0.43, compared to the broader market-4.00-2.000.002.004.00-0.432.54
The chart of Sortino ratio for VIR, currently valued at -0.32, compared to the broader market-4.00-2.000.002.004.00-0.323.40
The chart of Omega ratio for VIR, currently valued at 0.96, compared to the broader market0.501.001.502.000.961.47
The chart of Calmar ratio for VIR, currently valued at -0.29, compared to the broader market0.002.004.006.00-0.293.66
The chart of Martin ratio for VIR, currently valued at -1.05, compared to the broader market0.0010.0020.0030.00-1.0516.26
VIR
^GSPC

The current Vir Biotechnology, Inc. Sharpe ratio is -0.43. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Vir Biotechnology, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.

Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JuneJulyAugustSeptemberOctoberNovember
-0.43
2.54
VIR (Vir Biotechnology, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Vir Biotechnology, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-91.63%
-0.88%
VIR (Vir Biotechnology, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Vir Biotechnology, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Vir Biotechnology, Inc. was 91.89%, occurring on Nov 20, 2024. The portfolio has not yet recovered.

The current Vir Biotechnology, Inc. drawdown is 91.63%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-91.89%Jan 28, 2021961Nov 20, 2024
-57.62%Feb 28, 2020178Nov 9, 202052Jan 26, 2021230
-38.94%Feb 3, 202014Feb 21, 20203Feb 26, 202017
-25.36%Nov 6, 201915Nov 26, 201934Jan 16, 202049
-13.99%Jan 28, 20201Jan 28, 20203Jan 31, 20204

Volatility

Volatility Chart

The current Vir Biotechnology, Inc. volatility is 29.89%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%JuneJulyAugustSeptemberOctoberNovember
29.89%
3.96%
VIR (Vir Biotechnology, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Vir Biotechnology, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Vir Biotechnology, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items